A newly approved medication called sonidegib (Odomzo) gives physicians a second option in a class of medications designed to treat a small number of patients who suffer from locally advanced basal cell carcinoma and meet other criteria. Learn more
Randy Dotinga
Advertisement
Randy Dotinga is a medical writer based in San Diego, Calif.
Articles by Randy Dotinga
Advertisement
Latest Updated Articles
- Sonidegib offers new option for basal cell cancer
Published: December 9th 2015 | Updated:
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
ICYMI: First Patient Dosed in Global Phase 2 Study of Oral TYK2 Inhibitor Soficitinib for PN
3
Alpha-9 Begins First-in-Human Trial of MC1R-Targeted Radiotherapeutic
4
Rethinking Pathogenesis and Severity Assessment in Chronic Hand Eczema
5
